Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience

The aim of the present study was to evaluate the efficacy and safety of pegylated liposomal doxorubicin (PLD) in patients with Müllerian carcinoma treated at our hospital. Nineteen patients with platinum-resistant Müllerian carcinoma were treated with intravenous PLD 50 mg/m(2) every 4 weeks. Tumor...

Full description

Saved in:
Bibliographic Details
Main Authors: FUKUDA, TAKESHI, SUMI, TOSHIYUKI, TERAMAE, MASATOMO, NAKANO, YUSUKE, MORISHITA, MASANARI, TERADA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2013
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3525355/
https://ncbi.nlm.nih.gov/pubmed/23255889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.971
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items